首页 › 基金 › GLAZER CAPITAL, LLC › ESPR

GLAZER CAPITAL, LLC 对 ESPR 的持仓历史

ESPERION THERAPEUTICS INC NE

GLAZER CAPITAL, LLC 在 Q2 2026 的 13F 申报中披露持有 ESPR(ESPERION THERAPEUTICS INC NE)22,416,339 股,市值约 US$70.8M,约占其申报组合的 2.11%,在其申报持仓中市值排名第 8 位。 GLAZER CAPITAL, LLC 于 Q2 2026 首次申报该持仓。

最新持仓 (Q2 2026)22.42M 股
申报持仓市值$70.84M
组合权重2.11%
首次申报Q2 2026
最近变动新进
更新于2026-10-24

最后更新: 2026-10-24 · 来源: SEC EDGAR Form 13F-HR

GLAZER CAPITAL, LLC 对 ESPR 的持仓演变

GLAZER CAPITAL, LLC 于 Q2 2026 首次披露 ESPR 持仓:22,416,339 股(约 US$70.8M)。

逐季持仓明细

季度股数金额变化
Q2 2026 22.42M $70.84M 新进

关于 ESPR 与 13F 数据

ESPR(ESPERION THERAPEUTICS INC NE)的行业分类暂缺。我们追踪的基金中还有 40 只申报持有 ESPR,申报仓位最大的包括:ODDO BHF ASSET MANAGEMENT SAS (US$15.8M), Beryl Capital Management LLC (US$14.0M), PenderFund Capital Management Ltd. (US$12.3M)。 根据美国 SEC 规定,管理资产超过 1 亿美元的机构投资者须在每季度结束后 45 天内提交 13F 表,披露其美股多头持仓。该数据不包含空头、大部分期权及海外持仓,因此应将其视为季度快照而非实时仓位。

其它持有 ESPR 的基金

查看 ESPR 的全部基金持有人 →

常见问题

How long has GLAZER CAPITAL, LLC held ESPR?

GLAZER CAPITAL, LLC has disclosed ESPR holdings in 1 of the last 1 reported quarters, going back to Q2 2026.

What is GLAZER CAPITAL, LLC's current position in ESPR?

As of Q2 2026, GLAZER CAPITAL, LLC holds 22.42M shares of ESPR (ESPERION THERAPEUTICS INC NE), valued at $70.84M, representing 2.11% of its reported portfolio and ranking #8.

Has GLAZER CAPITAL, LLC been buying or selling ESPR?

In the latest 13F filing (Q2 2026), GLAZER CAPITAL, LLC newly opened its position in ESPR.

Which other funds hold ESPR?

Other major institutional holders of ESPR include ODDO BHF ASSET MANAGEMENT SAS, Beryl Capital Management LLC, PenderFund Capital Management Ltd., among 40 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.